Epstein-Barr virus-induced miR-155 attenuates NF-kappaB signaling and stabilizes latent virus persistence
about
The viral and cellular microRNA targetome in lymphoblastoid cell linesMiR-155 induction by F. novicida but not the virulent F. tularensis results in SHIP down-regulation and enhanced pro-inflammatory cytokine responseIn vivo microRNA-155 expression influences antigen-specific T cell-mediated immune responses generated by DNA vaccinationHelicobacter pylori induces miR-155 in T cells in a cAMP-Foxp3-dependent mannerThe A20 deubiquitinase activity negatively regulates LMP1 activation of IRF7Termination of NF-kappaB activity through a gammaherpesvirus protein that assembles an EC5S ubiquitin-ligaseVirally induced cellular microRNA miR-155 plays a key role in B-cell immortalization by Epstein-Barr virusMicroRNA miR-155 inhibits bone morphogenetic protein (BMP) signaling and BMP-mediated Epstein-Barr virus reactivationInduction of microRNA-155 is TLR- and type IV secretion system-dependent in macrophages and inhibits DNA-damage induced apoptosisOncogenic IRFs provide a survival advantage for Epstein-Barr virus- or human T-cell leukemia virus type 1-transformed cells through induction of BIC expressionReticuloendotheliosis virus strain T induces miR-155, which targets JARID2 and promotes cell survivalVirus meets host microRNA: the destroyer, the booster, the hijackerMammalian microRNA: an important modulator of host-pathogen interactions in human viral infectionsHuman metapneumovirus infection induces significant changes in small noncoding RNA expression in airway epithelial cells.Chromatin organization of gammaherpesvirus latent genomes.MiR-155 induction in microglial cells suppresses Japanese encephalitis virus replication and negatively modulates innate immune responses.Critical role of the virus-encoded microRNA-155 ortholog in the induction of Marek's disease lymphomas.MicroRNAs of the immune system: roles in inflammation and cancer.Upregulation of MiR-155 in nasopharyngeal carcinoma is partly driven by LMP1 and LMP2A and downregulates a negative prognostic marker JMJD1A.Epstein-Barr virus BART9 miRNA modulates LMP1 levels and affects growth rate of nasal NK T cell lymphomasA systems biology approach identified different regulatory networks targeted by KSHV miR-K12-11 in B cells and endothelial cellsAlteration of microRNA profiles in squamous cell carcinoma of the head and neck cell lines by human papillomavirus.The Epstein-Barr virus (EBV)-induced tumor suppressor microRNA MiR-34a is growth promoting in EBV-infected B cells.Kaposi's Sarcoma-Associated Herpesvirus microRNAs.Differential activation and functional specialization of miR-146 and miR-155 in innate immune sensing.Viral oncogenes, noncoding RNAs, and RNA splicing in human tumor virusesA microRNA encoded by Kaposi sarcoma-associated herpesvirus promotes B-cell expansion in vivomiRNAs in the pathogenesis of oncogenic human viruses.The importance of epigenetic alterations in the development of epstein-barr virus-related lymphomas.Sulfated small molecules targeting eBV in Burkitt lymphoma: from in silico screening to the evidence of in vitro effect on viral episomal DNA.miR-155: on the crosstalk between inflammation and cancer.Wolbachia uses host microRNAs to manipulate host gene expression and facilitate colonization of the dengue vector Aedes aegypti.Epstein-Barr Virus_Encoded LMP1 upregulates microRNA-21 to promote the resistance of nasopharyngeal carcinoma cells to cisplatin-induced Apoptosis by suppressing PDCD4 and Fas-L.Ectopic expression of microRNA-155 enhances innate antiviral immunity against HBV infection in human hepatoma cellsA Kaposi's sarcoma-associated herpesvirus-encoded ortholog of microRNA miR-155 induces human splenic B-cell expansion in NOD/LtSz-scid IL2Rγnull mice.Both MicroRNA-155 and Virus-Encoded MiR-155 Ortholog Regulate TLR3 Expression.MicroRNA-155 Reinforces HIV Latency.miR-155 regulates HGAL expression and increases lymphoma cell motility.Looking at Kaposi's Sarcoma-Associated Herpesvirus-Host Interactions from a microRNA Viewpoint.NF-κB/STAT5/miR-155 network targets PU.1 in FLT3-ITD-driven acute myeloid leukemia.
P2860
Q21131404-4B0FD984-B779-4FFD-A5AF-DA048D3C982AQ21142683-7412A1C6-DD64-4741-9733-116A7F11E9FFQ21195875-FB4B7820-5823-43DA-A91D-AA966E77F3AFQ21562669-2CB370B1-3D69-4D78-B298-BC9D4732A3E3Q24306662-C72E9520-CD98-4220-A41A-8E551143301BQ24309461-6213124B-59D6-4F9D-968C-5D31E4DAFD61Q24609270-B57E9816-FD22-489E-B4AC-485FD7846AE7Q24610098-57D8D049-7B84-4311-9068-B3293D58450BQ24617429-0B773710-1623-48CB-A571-7FF4C9390C2BQ24625246-BC9B312C-1BCF-48E1-848B-8650071C22DFQ24647397-2A9C247B-DE10-4D44-8052-A5E7DA26A88CQ27028188-69C2EFE4-FB7F-4169-A21B-65CCBC0A90FFQ28072142-EF4104A3-7D0D-49D6-A45A-ED141AA49BA5Q33694826-4454F1EF-267C-4F5F-B744-C8BCB6D49341Q33729584-8B7466C9-8A39-43BA-B900-5A7C7B51B99CQ33729909-6ECACE10-40C2-40A6-A4CB-D13902B2F1F1Q33839462-ADC5A01D-0805-4556-AB27-CEA01E0EB1C0Q33877654-A9D4E47A-9F8B-407E-A75D-EC3A26FC288BQ33889404-73CDA780-B552-4DDC-9724-AA51AE7F4C04Q34079271-2A676936-BAC0-4965-A457-D15C500AB1DAQ34100180-C60CACA9-654E-4E31-8794-DA5E0FE8E825Q34127590-75A800D0-E481-4051-BDE1-663FEB456714Q34267599-638F2DEE-D0EA-42D6-BE40-BED23E4A73AFQ34273195-1E3D9393-6934-4ECF-AB12-8ECAF4EC832AQ34311065-5DBE1A20-56E1-40F9-940C-DA356E17F182Q34394771-F3A2E1E0-365D-4965-89C8-42523C2A9785Q34490029-6592C732-A97C-4DB9-A81A-D8BA8F5A554DQ34504522-B42EA454-93EA-432A-BF0E-A23062FB5ED5Q34549462-2212282E-0FB4-4F7A-BB2D-8BAB9460EFABQ34563797-8D4182DF-EA4A-4533-8F26-14C28B304658Q35006975-0E521644-5294-479C-BB8D-741B9EB63BC8Q35022062-5AD41B6D-CE19-42CE-9902-6252EA83E0DAQ35032548-0E58C2E0-B9E9-45AD-A57F-56E2D7C5ED65Q35203879-85C8ACB1-0194-4BB8-A355-B71167DAC7FAQ35382266-F28E49A3-EC25-495E-B773-81D44A68F471Q35566848-B46300E4-BEB0-4251-BBF8-FCED4B70E2FEQ35662247-1AA07B41-29BC-4990-B94D-6C5F8A7808ECQ35669239-3BDA623D-BA3E-4F5A-B8A1-68BB115FD08DQ35671861-405A0CA5-FAB1-42C9-B43F-F48CD381BE8FQ35814995-3CB05CB5-1C84-43F8-B574-CB45E1157389
P2860
Epstein-Barr virus-induced miR-155 attenuates NF-kappaB signaling and stabilizes latent virus persistence
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Epstein-Barr virus-induced miR ...... lizes latent virus persistence
@ast
Epstein-Barr virus-induced miR ...... lizes latent virus persistence
@en
Epstein-Barr virus-induced miR ...... lizes latent virus persistence
@nl
type
label
Epstein-Barr virus-induced miR ...... lizes latent virus persistence
@ast
Epstein-Barr virus-induced miR ...... lizes latent virus persistence
@en
Epstein-Barr virus-induced miR ...... lizes latent virus persistence
@nl
prefLabel
Epstein-Barr virus-induced miR ...... lizes latent virus persistence
@ast
Epstein-Barr virus-induced miR ...... lizes latent virus persistence
@en
Epstein-Barr virus-induced miR ...... lizes latent virus persistence
@nl
P2093
P2860
P3181
P356
P1433
P1476
Epstein-Barr virus-induced miR ...... lizes latent virus persistence
@en
P2093
Andreas Weidmer
Chang-Gong Liu
Paul M Lieberman
P2860
P304
P3181
P356
10.1128/JVI.00752-08
P407
P577
2008-11-01T00:00:00Z